Literature DB >> 26266105

Morphometrical Analysis of Developing Cochlear Ganglion Neurons: A Light Microscopic Fetal Study.

Madhu Sethi1, Sabita Mishra2, Neelam Vasudeva3, J M Kaul4.   

Abstract

BACKGROUND AND AIM: The cochlear or spiral ganglion neurons are the initial bridge between the external world of sound and its discernment in the brain. As the developing human fetal cochlea is known to start functioning in mid gestational period, its anatomical details when compared with adults could vary with each gestational age. The aim of current study was to assess morphometrical parameter of developing human fetal cochlear ganglion neurons and comparison of data in each gestational period.
MATERIALS AND METHODS: Ten aborted human fetuses from 14th to 28th weeks of gestation were procured from Department of Obstetrics and Gynaecology of associated hospital, after obtaining ethical clearance and were processed for studying under light microscope. Area of neurons from each gestational age was measured on histophotomicrographs using image Proplus software. Standard statistical method was used to calculate area range and percentage of small and large ganglion neurons.
RESULTS: The neuronal area increased progressively in successively higher gestation age fetuses. In the fetus belonging to lowest gestational age the area ranged from 4-37μm2 while in highest gestational age fetus its range was 10-58.3μm2. The small ganglion neurons were higher in 14 weeks (65.5%) fetuses and 16-20 weeks (81.03%) fetuses, while in higher gestational age fetuses' large ganglion neuronal population was higher (62-66%).
CONCLUSION: A baseline morphometrical representation of fetal cochlear ganglion neurons could be of relevance in advanced human experimental studies on effect of neurotrophic factors in human fetuses with congenital deafness. It has been found that these factors directly influence neuronal maturation assessed by progressive increase in soma size and survival.

Entities:  

Keywords:  Development; Fetus; Neurons; Quantitative; Spiral ganglion

Year:  2015        PMID: 26266105      PMCID: PMC4525494          DOI: 10.7860/JCDR/2015/11323.5997

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  22 in total

1.  NT-3 and/or BDNF therapy prevents loss of auditory neurons following loss of hair cells.

Authors:  H Staecker; R Kopke; B Malgrange; P Lefebvre; T R Van de Water
Journal:  Neuroreport       Date:  1996-03-22       Impact factor: 1.837

2.  First appearance of type II neurons during ontogenesis in the spiral ganglion of the rat. An immunocytochemical study.

Authors:  A Hafidi; R Romand
Journal:  Brain Res Dev Brain Res       Date:  1989-07-01

3.  Degeneration behaviour of the cochlear nerve.

Authors:  H Spoendlin
Journal:  Arch Klin Exp Ohren Nasen Kehlkopfheilkd       Date:  1971

4.  Differentiation of cochlear afferent neurons.

Authors:  H Spoendlin
Journal:  Acta Otolaryngol       Date:  1981 May-Jun       Impact factor: 1.494

Review 5.  Rescue and regrowth of sensory nerves following deafferentation by neurotrophic factors.

Authors:  R A Altschuler; Y Cho; J Ylikoski; U Pirvola; E Magal; J M Miller
Journal:  Ann N Y Acad Sci       Date:  1999-11-28       Impact factor: 5.691

6.  The role of the neurotrophins in maturation and maintenance of postnatal auditory innervation.

Authors:  H Staecker; V Galinovic-Schwartz; W Liu; P Lefebvre; R Kopke; B Malgrange; G Moonen; T R Van De Water
Journal:  Am J Otol       Date:  1996-05

Review 7.  The use of neurotrophin therapy in the inner ear to augment cochlear implantation outcomes.

Authors:  Cameron L Budenz; Bryan E Pfingst; Yehoash Raphael
Journal:  Anat Rec (Hoboken)       Date:  2012-10-08       Impact factor: 2.064

8.  Protection of auditory neurons from aminoglycoside toxicity by neurotrophin-3.

Authors:  P Ernfors; M L Duan; W M ElShamy; B Canlon
Journal:  Nat Med       Date:  1996-04       Impact factor: 53.440

9.  Deafferentation-associated changes in afferent and efferent processes in the guinea pig cochlea and afferent regeneration with chronic intrascalar brain-derived neurotrophic factor and acidic fibroblast growth factor.

Authors:  Rudolf Glueckert; Mario Bitsche; Josef M Miller; Yaying Zhu; Diane M Prieskorn; Richard A Altschuler; Anneliese Schrott-Fischer
Journal:  J Comp Neurol       Date:  2008-04-01       Impact factor: 3.215

10.  Glial cell line-derived neurotrophic factor and chronic electrical stimulation prevent VIII cranial nerve degeneration following denervation.

Authors:  Sho Kanzaki; Timo Stöver; Kohei Kawamoto; Diane M Prieskorn; Richard A Altschuler; Josef M Miller; Yehoash Raphael
Journal:  J Comp Neurol       Date:  2002-12-16       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.